Nishita Medicare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 6 Year, 24 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 214594.79%
- Ebitda 319225.90%
- Net Worth 1075.16%
- Total Assets 6439.17%
About Nishita Medicare
Nishita Medicare Private Limited (NMPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 January 2019 (Six years 24 days old ). Its registered office is in Erode, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Songappagounder Kandasamy, Duraisamy Kandaswami, Pradeepa Subramanian, and One other member serve as directors at the Company.
Company Details
- Location
Erode, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100TZ2019PTC031620
- Company No.
031620
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jan 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Nishita Medicare?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Songappagounder Kandasamy  | Director | 11-Apr-2022 | Current |
| Duraisamy Kandaswami | Director | 30-Jan-2019 | Current |
| Pradeepa Subramanian | Director | 30-Jan-2019 | Current |
| Sudhakar Kandaswami | Director | 30-Jan-2019 | Current |
Financial Performance of Nishita Medicare.
Nishita Medicare Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 214594.79% increase in profit. The company's net worth Soared by an impressive increase of 1075.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nishita Medicare?
Unlock access to Nishita Medicare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Medinews Pharma India Private LimitedDuraisamy Kandaswami is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nishita Medicare?
Unlock and access historical data on people associated with Nishita Medicare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nishita Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nishita Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.